Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR3C1 |
| Upstream (Parents) |
|---|
| (<<) DPYD → NR3C1 |
| (<<) FERMT2 → NR3C1 |
| (<<) SDC2 → NR3C1 |
| (<<) IL1R1 → NR3C1 |
| Downstream (Children) |
|---|
| NR3C1 → SNX24 (>>) |
| NR3C1 → LOC652637///WHAMML1 (>>) |
| NR3C1 → U2AF2 (>>) |
| NR3C1 → GLYR1///SEPT6 (>>) |
| NR3C1 → TTC28 (>>) |
| NR3C1 → PALM (>>) |
| NR3C1 → EGR1 (>>) |
| NR3C1 → PLA2G4C (>>) |
| NR3C1 → S1PR1 (>>) |
| NR3C1 → DOCK4 (>>) |
| NR3C1 → FAT4 (>>) |
| NR3C1 → SGMS1 (>>) |
| NR3C1 → ARHGAP10 (>>) |
| NR3C1 → C14orf139 (>>) |
| NR3C1 → MYO5C (>>) |
| NR3C1 → NLGN4X (>>) |
| NR3C1 → IL18R1 (>>) |
| NR3C1 → DPYD (>>) |
| NR3C1 → ENPP2 (>>) |
| NR3C1 → ARSD (>>) |
| NR3C1 → FERMT2 (>>) |
| NR3C1 → SDC2 (>>) |
| NR3C1 → CD1C (>>) |
| NR3C1 → VCX2 (>>) |
| NR3C1 → TLR3 (>>) |
| NR3C1 → ANXA8L1///ANXA8///ANXA8L2 (>>) |
| NR3C1 → GRIK5 (>>) |
| NR3C1 → GNAI1 (>>) |
| NR3C1 → SNX10 (>>) |
| NR3C1 → IGFBP4 (>>) |
| NR3C1 → EFNA4 (>>) |
| NR3C1 → CTSG (>>) |
| NR3C1 → TMEM106C (>>) |
